SCHEMBL391028

SCHEMBL391028

NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 1/20 0.43
SLC6A9 P48067 1/20 0.43
OR51E2 Q9H255 1/20 0.43
TERT O14746 1/20 0.40
ALDH1A1 P00352 5/20 0.38
EGLN1 Q9GZT9 2/20 0.38
ITGB1 P05556 1/20 0.37
ITGA5 P08648 1/20 0.37
MAPT P10636 3/20 0.37
LMNA P02545 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
PTGS2 P35354 1/20 0.37
KDM4E B2RXH2 2/20 0.36
HIF1A Q16665 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
SLC22A8 Q8TCC7 1/20 0.36
FAAH O00519 5/20 0.36
MMP2 P08253 1/20 0.35
PTPN1 P18031 1/20 0.35
CTH P32929 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93766 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1
SCHEMBL6674512 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1
SCHEMBL6674893 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1
SCHEMBL1402291 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1
SCHEMBL6130185 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1
Glycylglycylglycine SCHEMBL98565 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1
SCHEMBL6677616 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1
SCHEMBL391787 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1
SCHEMBL6120072 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1
SCHEMBL4586328 1.00 GLRA1 (0.43) GLRA1SLC6A9OR51E2TERTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4496 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026041129-A1 LIGAND-CYTOTOXICITY DRUG CONJUGATES AND PHARMACEUTICAL USES THEREOF HANSOH BIO LLC (US) 2026-02-26 WO claimed
US-20260027224-A1 ANTIBODY-DRUG CONJUGATES TARGETING CDH3 AND PREPARATION METHODS AND USES THEREOF SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD (CN) 2026-01-29 US claimed
US-20260014270-A1 ANTI-CEACAM5 ANTIBODY-DRUG CONJUGATE AND METHOD FOR PREPARATION AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2026-01-15 US claimed
EP-4674840-A1 CHEMICAL COUPLING LINKER AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2026-01-07 EP claimed
US-20250346606-A1 CAMPTOTHECIN COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2025-11-13 US claimed
EP-4631952-A1 GLUCOCORTICOID RECEPTOR AGONIST AND CONJUGATE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2025-10-15 EP claimed
US-20250281631-A1 ANTIBODY-DRUG CONJUGATES AND PREPARATION METHODS AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2025-09-11 US claimed
EP-4601701-A1 ANTIBODY-DRUG CONJUGATE BINDING TO HUMAN PTK7 AND METHOD FOR PREPARATION AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2025-08-20 EP claimed
EP-4603109-A1 ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2025-08-20 EP claimed
EP-4603487-A1 HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2025-08-20 EP claimed
US-5837673-A ANTITUMOR AGENTS AND ANTICARCINOGENIC AGENTS TANABE SEIYAKU CO., LTD. (JP) 1998-11-17 US claimed
US-5734016-A GENETIC ENGINEERING THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1998-03-31 US claimed
CN-1158334-A Camptothecin derivatives TANABE SEIYAKU CO (JP) 1997-09-03 CN claimed
EP-0781781-A2 Camptothecin derivatives TANABE SEIYAKU CO., LTD. (JP) 1997-07-02 EP claimed
EP-0757049-A1 Camptothecin derivatives TANABE SEIYAKU CO., LTD. (JP) 1997-02-05 EP claimed
EP-0560913-A1 BIFUNCTIONAL INHIBITORS OF THROMBIN AND PLATELET ACTIVATION BIOGEN, INC. (US) 1993-09-22 EP claimed
WO-1992010575-A1 BIFUNCTIONAL INHIBITORS OF THROMBIN AND PLATELET ACTIVATION BIOGEN, INC. (US) 1992-06-25 WO claimed
EP-0190254-A4 CLONED GENE AND METHOD FOR MAKING AND USING THE SAME. GENEX CORP (US) 1987-03-09 EP claimed
EP-0190254-A1 CLONED GENE AND METHOD FOR MAKING AND USING THE SAME GENEX CORPORATION (US) 1986-08-13 EP claimed
WO-1986000528-A1 CLONED GENE AND METHOD FOR MAKING AND USING THE SAME GENEX CORPORATION (US) 1986-01-30 WO claimed